Provided by Tiger Trade Technology Pte. Ltd.

Dianthus Therapeutics Inc.

104.13
-1.7100-1.62%
Volume:184.14K
Turnover:19.12M
Market Cap:5.82B
PE:-25.32
High:106.00
Open:105.34
Low:102.38
Close:105.84
52wk High:117.88
52wk Low:23.39
Shares:55.93M
Float Shares:55.85M
Volume Ratio:0.49
T/O Rate:0.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1130
EPS(LYR):-4.2037
ROE:-26.07%
ROA:-17.69%
PB:4.97
PE(LYR):-24.77

Loading ...

TD Cowen Keeps Their Buy Rating on Dianthus Therapeutics (DNTH)

TIPRANKS
·
Jun 14

Dianthus’ new CAPTIVATE responder rate beat expectations, says Raymond James

TIPRANKS
·
Jun 13

Dianthus reports additional data from Part A of CAPTIVITY study

TIPRANKS
·
Jun 13

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 13

Dianthus rises 7.7%

TIPRANKS
·
Jun 13

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 11

Dianthus price target raised to $132 from $110 at Jefferies

TIPRANKS
·
Jun 11

Dianthus Therapeutics Down Over 9%, On Track for Largest Percent Decrease Since January 2025 -- Data Talk

Dow Jones
·
Jun 11

Analysts’ Top Healthcare Picks: Dianthus Therapeutics (DNTH), Cullinan Management (CGEM)

TIPRANKS
·
Jun 11

Dianthus falls -13.7%

TIPRANKS
·
Jun 10

Dianthus sinks after Sanofi halts CIDP Phase 3 study

TIPRANKS
·
Jun 10

Dianthus Therapeutics (DNTH) Is Down 10.0% After FDA Eases Claseprubart Trials And Grants Orphan Status

Simply Wall St.
·
Jun 08

Dianthus Therapeutics EVP, Head of R&D Simrat Randhawa disposes of shares worth $2.4 million

Reuters
·
Jun 03

Dianthus Therapeutics grants 60,000 inducement stock options at $89.45 per share

Reuters
·
Jun 03

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 03

Dianthus Therapeutics to present at Jefferies Global Healthcare Conference

Reuters
·
May 27

Dianthus Therapeutics shareholders elect Class II directors at annual meeting

Reuters
·
May 23

Dianthus Therapeutics director Paula Soteropoulos disposes of 599 shares worth $51,196.53

Reuters
·
May 12

Dianthus price target lowered to $120 from $122 at Evercore ISI

TIPRANKS
·
May 12

Should Dianthus Therapeutics’ (DNTH) Big Cash Raise and LBL-047 Bet Prompt Investor Reassessment?

Simply Wall St.
·
May 11